Industrial Synthesis and Purity Profile of 4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione
- High-Yield Claisen Condensation: Optimized reaction pathways using sodium methoxide and toluene achieve yields exceeding 85%.
- Stringent Impurity Control: Advanced crystallization and activated carbon treatment ensure HPLC purity greater than 99.9%.
- Scalable Manufacturing: Robust processes designed for bulk procurement with consistent particle size distribution (D90 < 200 microns).
The production of non-steroidal anti-inflammatory drugs (NSAIDs) relies heavily on the availability of high-quality key starting materials. Among these, 4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione (CAS: 720-94-5) serves as a critical Celecoxib intermediate. This fluorinated beta-diketone is essential for constructing the pyrazole core found in the final active pharmaceutical ingredient (API). At NINGBO INNO PHARMCHEM CO.,LTD., we specialize in the large-scale organic synthesis of this compound, ensuring that every batch meets rigorous international standards for industrial purity and consistency.
Optimized Synthetic Pathway Overview
The core manufacturing process for 4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione involves a Claisen condensation reaction. This transformation typically reacts 4-methylacetophenone with an alkyl ester of trifluoroacetic acid, such as methyl trifluoroacetate or isopropyl trifluoroacetate. The reaction is catalyzed by a strong base, with sodium methoxide being the preferred choice due to its reactivity profile and cost-effectiveness in large-scale operations.
Solvent selection plays a pivotal role in maximizing yield and simplifying downstream processing. Industrial protocols often utilize toluene or ethyl acetate as the primary reaction medium. Data indicates that conducting the reaction in toluene at reflux temperatures (approximately 110°C) allows for complete conversion while facilitating the removal of alcohol byproducts via azeotropic distillation. Alternatively, biphasic systems containing ethyl acetate and water can be employed for specific workup procedures. The resulting fluorinated ketone is typically isolated after acidic quenching and solvent removal under vacuum.
Our technical team has refined this synthesis route to minimize side reactions. By controlling the addition rate of the trifluoroacetate ester and maintaining precise temperature gradients between 25°C and reflux, we mitigate the formation of polymeric byproducts. This attention to detail ensures that the crude material enters the purification stage with a high baseline quality, reducing the load on final crystallization steps.
Impurity Control Methods During Manufacturing
Achieving API-ready quality requires stringent management of process-related impurities. During the synthesis of this intermediate, specific structural analogs may form, often designated in technical literature as Formula VII and Formula VIII impurities. To address this, our purification strategy incorporates a multi-step crystallization process using aromatic hydrocarbon solvents, with toluene being the preferred medium.
The purification workflow involves dissolving the crude intermediate in heated toluene, followed by treatment with activated carbon. This step is critical for removing colored impurities and reducing heavy metal content to negligible levels. Subsequent cooling of the solution to between 0°C and 15°C induces crystallization, allowing for the isolation of the pure product via filtration. This method consistently delivers material with an HPLC purity of at least 99.9% by weight.
When sourcing high-purity pharmaceutical grade materials, buyers should verify the residual solvent content. Our manufacturing guidelines adhere to strict limits, ensuring residual solvents remain below 0.1% by weight as determined by Gas Chromatography (GC). Furthermore, every shipment is accompanied by a comprehensive COA (Certificate of Analysis) that details impurity profiles and spectroscopic data, providing full transparency for quality assurance teams.
Scale up Considerations for Production
Transitioning from laboratory synthesis to commercial production introduces unique challenges regarding heat transfer, mixing efficiency, and safety. As a leading global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. utilizes reactor systems designed to handle the exothermic nature of the condensation reaction safely. Scale-up parameters are validated to ensure that reaction kinetics observed in small batches are replicated accurately in multi-ton production runs.
Particle size distribution is another critical parameter for downstream processing. The physical characteristics of the intermediate can influence the filtration rate and the subsequent reaction kinetics when converting to Celecoxib. Our standard specifications target a D90 value of less than 200 microns, with a D50 typically under 50 microns. If specific micronization is required for a client's process, we offer milling services to adjust the particle size distribution according to precise technical requirements.
Commercial viability also depends on consistent supply chains and competitive bulk price structures. By optimizing raw material procurement and solvent recovery systems, we maintain cost efficiency without compromising on quality. This makes us a reliable chemical supplier for pharmaceutical companies seeking long-term partnerships for API intermediate production.
Technical Specifications and Process Parameters
The following table outlines the standard quality specifications and process conditions maintained during the production of 4,4,4-Trifluoro-1-(4-methylphenyl)-1,3-butanedione.
| Parameter | Specification / Condition | Method |
|---|---|---|
| Chemical Name | 4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione | - |
| CAS Number | 720-94-5 | - |
| Assay (HPLC) | ≥ 99.5% (Standard), ≥ 99.9% (Premium) | HPLC |
| Related Impurities | Individual < 0.1%, Total < 0.5% | HPLC |
| Residual Solvents | < 0.1% (w/w) | GC |
| Particle Size (D90) | < 200 microns | Laser Diffraction |
| Reaction Solvent | Toluene / Ethyl Acetate | - |
| Reaction Temperature | 25°C to Reflux (110°C) | - |
In conclusion, the reliable supply of 4,4,4-Trifluoro-1-(4-methylphenyl)butane-1,3-dione requires a partner with deep technical expertise in fluorinated chemistry. Through optimized condensation reactions, rigorous impurity profiling, and scalable manufacturing capabilities, we ensure that our clients receive material that facilitates efficient API production. For technical inquiries or bulk procurement requests, our team is ready to support your supply chain needs with precision and reliability.